A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece
Study Identifier
P19-568
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Recruitment Complete
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18+ years
Protocol Summary
This study is being done to evaluate the clinical outcomes of Chronic Lymphocytic Leukemia (CLL) participants treated with venetoclax as routine standard of care in Greece. The decision to treat with venetoclax is made by the participant's physician prior to being offered enrollment in this study.
The objectives of this study include determining overall response rate, assessing safety information, analyzing patient profiles and disease characteristics and participant quality of life.
Study Locations
Location
Status
Location
Henry Dunnant Hospital Center /ID# 241682
Athens, Attica, Greece, 11526
Status
Not applicable
Location
General Hospital of Athens Gennimatas /ID# 212917
Athens, Attica, Greece, 11527
Status
Not applicable
Location
General Hospital of Athens Laiko /ID# 212902
Athens, Attica, Greece, 11527
Status
Not applicable
Location
General Hospital of Athens Laiko /ID# 230222
Athens, Attica, Greece, 11527
Status
Not applicable
Location
University General Hospital Attikon /ID# 212915
Athens, Attica, Greece, 12462
Status
Not applicable
Location
Metropolitan General /ID# 212934
Cholargós, Attica, Greece, 15562
Status
Not applicable
Showing {first} - {last} of {total} Results